These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 19396409

  • 1. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
    Marazzi G, Gebara O, Vitale C, Caminiti G, Wajngarten M, Volterrani M, Ramires JA, Rosano G, Fini M.
    Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
    [Abstract] [Full Text] [Related]

  • 2. Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease.
    Vitale C, Wajngaten M, Sposato B, Gebara O, Rossini P, Fini M, Volterrani M, Rosano GM.
    Eur Heart J; 2004 Oct; 25(20):1814-21. PubMed ID: 15474696
    [Abstract] [Full Text] [Related]

  • 3. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
    Di Napoli P, Di Giovanni P, Gaeta MA, Taccardi AA, Barsotti A.
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
    [Abstract] [Full Text] [Related]

  • 4. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R, Lacalaprice F, Faccenda E, Volpe L.
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [Abstract] [Full Text] [Related]

  • 5. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R.
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [Abstract] [Full Text] [Related]

  • 6. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.
    Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM.
    Int J Cardiol; 2007 Aug 09; 120(1):79-84. PubMed ID: 17134770
    [Abstract] [Full Text] [Related]

  • 7. Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study.
    Rosano GM, Vitale C, Sposato B, Mercuro G, Fini M.
    Cardiovasc Diabetol; 2003 Nov 28; 2():16. PubMed ID: 14641923
    [Abstract] [Full Text] [Related]

  • 8. Effects of trimetazidine on myocardial perfusion and left ventricular systolic function in type 2 diabetic patients with ischemic cardiomyopathy.
    Belardinelli R, Cianci G, Gigli M, Mazzanti M, Lacalaprice F.
    J Cardiovasc Pharmacol; 2008 Jun 28; 51(6):611-5. PubMed ID: 18574390
    [Abstract] [Full Text] [Related]

  • 9. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
    Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A.
    Am Heart J; 2003 Nov 28; 146(5):E18. PubMed ID: 14597947
    [Abstract] [Full Text] [Related]

  • 10. The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
    Grabczewska Z, Białoszyński T, Szymański P, Sukiennik A, Swiatkiewicz I, Koziński M, Kochman W, Grześk G, Kubica J.
    Cardiol J; 2008 Nov 28; 15(4):344-50. PubMed ID: 18698543
    [Abstract] [Full Text] [Related]

  • 11. A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.
    Fragasso G, Palloshi A, Puccetti P, Silipigni C, Rossodivita A, Pala M, Calori G, Alfieri O, Margonato A.
    J Am Coll Cardiol; 2006 Sep 05; 48(5):992-8. PubMed ID: 16949492
    [Abstract] [Full Text] [Related]

  • 12. Comparison of trimetazidine with atenolol in patients with syndrome X: effects on diastolic function and exercise tolerance.
    Leonardo F, Fragasso G, Rossetti E, Dabrowski P, Pagnotta P, Rosano GM, Chierchia SL.
    Cardiologia; 1999 Dec 05; 44(12):1065-9. PubMed ID: 10687257
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effects of trimetazidine treatment on exercise tolerance and B-type natriuretic peptide and troponin T plasma levels in patients with stable ischemic cardiomyopathy.
    Di Napoli P, Di Giovanni P, Gaeta MA, D'Apolito G, Barsotti A.
    Am Heart J; 2007 Sep 05; 154(3):602.e1-5. PubMed ID: 17719313
    [Abstract] [Full Text] [Related]

  • 14. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
    Sisakian AS, Torgomian AL, Barkhudarian AL.
    Klin Med (Mosk); 2006 Sep 05; 84(10):55-8. PubMed ID: 17201276
    [Abstract] [Full Text] [Related]

  • 15. Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease.
    Rosano GM, Marazzi G, Patrizi R, Cerquetani E, Vitale C, Volterrani M, Fini M, Mercuro G.
    Am J Cardiol; 2005 Feb 01; 95(3):327-31. PubMed ID: 15670539
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic value of trimetazidine in patients with coronary heart disease and left ventricular dysfunction].
    Multicentral Collaborative Group on Trimetazidine (Phase IV).
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Sep 01; 33(9):793-5. PubMed ID: 16266453
    [Abstract] [Full Text] [Related]

  • 17. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure.
    Fragasso G, Perseghin G, De Cobelli F, Esposito A, Palloshi A, Lattuada G, Scifo P, Calori G, Del Maschio A, Margonato A.
    Eur Heart J; 2006 Apr 01; 27(8):942-8. PubMed ID: 16510466
    [Abstract] [Full Text] [Related]

  • 18. Clinical benefits of a metabolic approach in the management of coronary patients.
    Marzilli M.
    Rev Port Cardiol; 2000 Nov 01; 19 Suppl 5():V25-30. PubMed ID: 11206100
    [Abstract] [Full Text] [Related]

  • 19. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances].
    Petelina TI, Gapon LI, Bakhmatova IuA, Zhevagina IA.
    Ter Arkh; 2005 Nov 01; 77(8):19-23. PubMed ID: 16206600
    [Abstract] [Full Text] [Related]

  • 20. [Clinical and hemodynamic efficacy of selective beta-blocker bisoprolol and cytoprotector trimetazidine in the treatment of chronic cardiac failure in patients with ischemic heart disease].
    Fedorova TA, Il'ina IuV, Sotnikova TI, Rybakova MK, Loshchits NV.
    Ter Arkh; 2004 Nov 01; 76(3):62-8. PubMed ID: 15108463
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.